General Statement of Disclosure:

CONSULTING FEES/HONORARIA: Amgen Inc.(MODEST), Astra Zeneca(SIGNIFICANT), Bayer(SIGNIFICANT), Boehringer Ingelheim Pharmaceuticals, Inc(SIGNIFICANT), Array(MODEST), Bristol-Myers Squibb Company (MODEST), CVRx(MODEST), G3 Pharmaceutical(MODEST), Innolife(MODEST), Janssen Pharmaceuticals, Inc(SIGNIFICANT), Luitpold Pharmaceuticals, Inc(MODEST), Medtronic(MODEST), Merck & Co., Inc.(SIGNIFICANT), Novartis Corporation(SIGNIFICANT), Relypsa(SIGNIFICANT), Vifor(SIGNIFICANT)

View Full Disclosure